Embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs) offer great promise in regenerative medicine and disease modeling due to their unlimited self-renewal and broad differentiation capacity. There is evidence that the growth properties and critical signaling pathways differ between murine and human ESCs; therefore, it is essential to perform functional studies to test the putatively conserved mechanisms of pluripotent stem cell self-renewal between species. Previously, we identified the transcription factor Zfx as a key regulator of self-renewal in murine ESCs. Here we extend those findings to human ESCs. ZFX knockdown in hESCs hindered clonal growth and decreased colony size after serial replating. ZFX overexpression enhanced clone formation in the presence of Y-27632, increased colony size at low density and decreased expression of differentiation-related genes in human ESCs. ZFX-overexpressing hESCs resisted spontaneous differentiation but could be directed to differentiate into endodermal and neural cell fates when provided with the appropriate cues. Thus, ZFX acts as a molecular rheostat regulating the balance between self-renewal and differentiation in hESCs, revealing the close evolutionary conservation of the self-renewal mechanisms in murine and human ESCs.
Introduction
Embryonic stem cells (ESCs) and the related induced pluripotent stem cells (iPSCs) are unique cells capable of giving rise to all tissues of the adult organism. These pluripotent stem cells (PSCs) can be exponentially expanded in culture while retaining their differentiation potential. The traits of pluripotency and continuous self-renewal underlie the value of PSCs as a potential source for cell replacement therapies and disease modeling, as well as a tool to study normal human development [1] [2] [3] . The pluripotency of both mouse and human ESCs is regulated by a network of ESCspecific transcription factors including Oct4, Nanog, Sox2 and their binding partners and targets [4, 5] . These factors promote the undifferentiated state by positively regulating expression of pluripotency related genes while repressing lineage-specific gene expression and maintaining the unique permissive chromatin structure of ESCs. In addition to ESC-specific transcription factors, additional sets of regulators appear essential for the selfrenewal of undifferentiated ESCs and/or iPSCs, including Klf family members, c-Myc and Lin28 [6, 7] . Understanding the exact role and mechanism of action of these and other regulators in ESC self-renewal is an important goal in developmental biology and will aid the practical use of PSCs.
Although ESCs from different species share the same key properties of pluripotency and self-renewal, major differences were found between murine (mESCs) and human ESCs (hESCs) including expression of different sets surface markers and distinct growth factor requirements [8] . Compared to mouse ESCs, hESCs display a characteristic flattened colony morphology, relatively slow growth and inefficient clonal propagation [3] . These properties resemble mouse epiblast-derived stem cells (EpiSC -referred to as ''primed'' hereafter), and indeed the gene expression profile of hESCs is closer to that of mouse EpiSC [9, 10] . Thus, current evidence suggests that hESCs are derived from a later developmental stage (primed) relative to the stage from which mouse ESCs are derived (naïve). Some progress has been made to push human ESCs toward the naïve state through genetic manipulation or by altering culture conditions [11, 12] , but much work remains in order to unravel the differences between pluripotent state and species differences. While the ''primed'' model of hESCs might reconcile some of the differences between murine and human ESCs, it opens a fundamental question about the similarity of the transcriptional circuitry between the two ESC types.
Previously, we demonstrated a role for the transcription factor Zfx in the self-renewal of mESC and adult hematopoietic stem cells [13] . Zfx is encoded on the mammalian X chromosome and contains a transcription activation domain and a zinc finger domain for sequence-specific DNA binding. A highly homologous protein called Zfy is encoded on the Y chromosome and is expressed in human but not in murine male somatic cells. ZFX/ ZFY genes are highly conserved in vertebrates, with ,97% amino acid identity between murine and human ZFX in the DNA binding domain. The deletion of Zfx in mESC impairs selfrenewal but does not affect differentiation capacity. Conversely, Zfx overexpression enhanced mESC self-renewal under suboptimal conditions and opposed both spontaneous and directed differentiation. Zfx directly activated functionally relevant mESCspecific target genes such as Tbx3 and Tcl1. Subsequent work has implicated Zfx in a common genetic pathway with Myc and Klf4, the two transcription factors controlling mESC self-renewal and iPSC reprogramming [14] [15] [16] . Thus, Zfx emerged as an essential and specific regulator of self-renewal in mESC, warranting the investigation of its role in the human system.
Here, we used a genetic approach to analyze the role of ZFX in hESC self-renewal and differentiation. Lentiviral shRNA knockdown of ZFX impaired self-renewal of hESCs. A novel bacterial artifical chromosome (BAC) transgenic strategy [17] was adapted to overexpress human ZFX in hESC under its native regulatory elements. Such gene dosage analysis showed that ZFX overexpression increased colony formation from single cells, a hallmark of improved hESC self-renewal. Furthermore, ZFX overexpression prevented spontaneous hESC differentiation under suboptimal conditions. Array analysis showed that ZFX overexpression decreased a number of genes characteristic of differentiated cells. These data establish an important role for ZFX in the regulation of hESC, confirming the conservation of self-renewal mechanisms in murine and human ESC.
Materials and Methods

ZFX Knockdown Human ESCs
H9 (WA-09) hESCs were maintained on MEFs (GlobalStem, Inc., Rockville, MD) before feeder-free expansion on Matrigel with conditioned media and 10 ng/ml FGF2 (3-5 days). To prepare cells for transduction, hESCs were exposed to Accutase (Innovative Cell Technologies, Inc., San Diego, CA) to create a single-celled suspension before plating at 18,000 cells/cm 2 in the presence of 10 mM Y-27632. The following day, cells were transduced at a multiplicity of infection of 1 and 0.1. For each knockdown, phenotypes were observed at both multiplicities relative to the scrambled control. Puromycin selection began two days after transduction and no mock transduced cells remained two days after selection began. At this time, 5,000 puromycin resistant cells were replated per condition and were expanded in conditioned media +10 ng/ml FGF2 for seven days before crystal violet staining.
Quantitative Immunofluoresce
Cells were transduced at a multiplicity of ,0.1 as described above and puromycin selection was applied as described. Cells were fixed in 4% paraformaldehyde for 15 minutes before rinsing four times with PBS. Fixed cells were blocked/permeabilized with 16 Perm/wash buffer (BD Biosciences, San Jose, CA) for 20 minutes before exposure to ZFX primary antibody overnight at 4uC. The next day, cells were washed three times in Perm/wash buffer before exposure to secondary antibodies conjugated to Alexa 488 and Hoechst 33258. Cells were washed three times after the hour, and PBS was added to the cells for imaging.
Imaging was performed on an Operetta High Content Screening System. The Hoechst was exposed for 20 mSec and the Alexa 488 signal was captured by a 300 mSec exposure using 50% intensity from the light source. Harmony software version 3.0 was used to identify cell nuclei (Hoechst signal) and quantitated the Alexa 488 pixel intensity (ZFX protein) for each cell nucleus. The mean pixel intensity from 50 cell fields per sample were imaged from 3 independent experiments for quantitation. All knockdowns were significantly different from the scrambled control (p,0.0001 for pairwise t-tests). 11,803 (Scr), 10,296 (Z2), 4,765 (Z3) and 6,905 (Z4) nuclei were measured in these experiments.
ZFX Overexpressing Human ESCs
Human ESCs were maintained as previously described [18] . BAC overexpressing human ESCs were made essentially as described for transgenic reporter BAC integration [17] . Briefly, H9 (WA-09) hESCs were maintained on MEFs (GlobalStem, Inc., Rockville, MD) before feeder-free expansion on Matrigel with conditioned media and 10 ng/ml FGF2 (3-5 days). To prepare cells for nucleofection, Accutase (Innovative Cell Technologies, Inc., San Diego, CA) was used to create a single-celled suspension, and 5 million cells were used per nucleofection (solution V, protocol B-16; Lonza, Cologne, Germany) with 3 ug of human Zfx BAC (RP11-1107D4) retrofitted with pRetroES [19] . Each nucleofection reaction was plated onto Neo-resistant MEFs (GlobalStem, Inc., Rockville, MD) in 10 mM Y-27632 for two days after nucleofection (Tocris Bioscience, Bristol, UK), and cells were allowed to recover for 4 days. Selection began with 25 ug/ml G418 (days 4-14; Invitrogen Life Science, Carlsbad, CA) before increasing selection to 40 ug/ml (days [14] [15] [16] [17] [18] [19] [20] . Drug-resistant colonies were manually dissected before expansion into lines.
Quantitative PCR Analysis
Real-time PCR analysis was performed using the following QuantiTect primers: POU5F1, CXCR4, PAX6, GAPDH and ACTN2. Other gene expression levels were determined by qPCR using the following primers: ZFX F: 59-CGTAGGAGAGGAGGATGCTG-39 R: 59-TGCCTGGAATCAGGTCTTCT-39 EOMES F: 59-CGGCCTCTGTGGCTCAAA-39 R: 59-AAGGAAACATGCGCCTGC-39 ID2 F: 59-AATCCTGCAGCACGTCATCG-39 R: 59-CTGGTGATGCAGGCTGACAA-39 VIM F: 59-GGAGCTGCAGGAGCTGAATG-39 R: 59-GACTTGCCTTGGCCCTTGAG-39 Septin 5 F: 59-TCAACATCGTGCCTCTCATC-39 R: 59-GCTGCTTGAAGTCCTCATCC-39 RNA was isolated using Trizol (Invitrogen, #15596-018) and reversed transcribed with the QuantiTect Reverse Transcription kit (Qiagen, #205313). SYBR green PCR reactions were performed using the PerfeCta SYBR Green SuperMix (Quanta Bioscience, #95054-500) on an Eppendorf Mastercycler Realplex 2 .
Stem Cell Marker Expression
Direct immunofluorescence was performed using SSEA-4 Alexa FluorH 488 (BD Pharmingen, #560308, La Jolla, CA), TRA1-81 Alexa FluorH 555 (BD Pharmingen, #560123, La Jolla, CA), and Oct3/4 Alexa FluorH 647 (BD Pharmingen, #560307, La Jolla, CA) according to the manufacturers recommendations.
Western Blotting
Protein samples of H9 hESC and ZFX Over hESC clones were prepared in RIPA buffer plus protease inhibitors (Roche Diagnostics Ltd.). Protein concentration was determined using Bradford assay and 30 ug or 15 ug of each sample were separated by 10% polyacrylamide gel. Gels were transferred to PVDF membranes using the Bio-Rad mini-gel transfer apparatus. Membranes were blocked with 3% milk for 1 hour at room temperature and probed with affinity-purified polyclonal anti-Zfx antibody (in 3% Milk, 1:1000 overnight at 4uC). After washing 3X with TBST, membranes were next incubated with peroxidaselabeled goat anti-rabbit IgG (1:10,000 in 3% milk) for 1 hour at room temperature before visualization with ECL.
Spontaneous Differentiation Assay
Human ESCs were expanded on Matrigel-coated dishes in standard human ESC media containing 6 ng/ml FGF2 without conditioned media. After seven days, single-celled suspensions were made by dissociating cells with Accutase (Innovative Cell Technologies, Inc., San Diego, CA) for 45 minutes before being washed twice with human ESC media. Aliquots of the cells were stained with anti-SSEA-3 (SSEA-3 Alexa FluorH 647; unpublished, BD Pharmingen, La Jolla, CA) and anti-SSEA-1 antibodies (SSEA-1 Alexa FluorH 647; BD Pharmingen #560120, La Jolla, CA) before quantitation on a FACSAria. For this assay, a number of unrelated BAC transgenic cell lines were used as normal clone controls (see Table 1 ). These lines do not overexpress ZFX but have undergone the same clonal selection as the ZFX Over clones (data not shown). Control clones were made from BACs with: ID1::YFP (clone 2) [20] , HES5::GFP (clone 10) and DLL1::GFP (clones 281 and 277) [17] . All control clones were derived from H9 hESC and were made with the same nucleofection/selection protocol [17] .
Clonogenic Assay
For colony-forming cell assays, human ESC were dissociated with Accutase (Innovative Cell Technologies, Inc., San Diego, CA) for 45 minutes. Dissociated cells were washed twice with human ESC media. Serial dilutions of hESCs were plated onto Matrigelcoated 6 well dishes in conditioned media with 10 ng/ml FGF2. Cells were exposed to Y-27632 for 24 hours after plating, and colonies were visualized after 7 days by staining with crystal violet. The data presented are the number of colonies from the 1:100 dilution and represent the number of colonies derived from 2,666 cells in 9.6 cm 2 .
Crystal violet staining was used because it is easier and cheaper and works as well for determining the number of colony forming units in a given culture. Figure S1A shows the alkaline phosphatase staining (Sigma, 86R-1KT) in the colony-forming assay: nearly every colony stains positive. We confirmed this result by growing clonal colonies before performing Oct4 FACS analysis ( Figure S1B ). Over 97.5% of the cells from all genotypes were Oct4+ demonstrating that these growth conditions strongly select for undifferentiated hESCs. This makes alkaline phosphatase detection a redundant feature of the colony growth assay.
Directed Differentiation
To direct human ESCs to endoderm, we used a previously published protocol [21] . Briefly, endoderm induction was performed by switching from hESC media to RPMI with glutamine, 0.5% Hyclone FBS and 100 ng/ml Activin A. Cells were fed daily and were assayed on days 1 and 3. ESCs were directed to neural cells through co-culture with MS-5 bone marrow stromal cells as previously described [18] .
Gene Expression Array
RNA was isolated from the Tra1-81 HI /SSEA-3 HI fraction of ZFX Over1,2 , ZFX Normal and H9 hESCs using Trizol (Invitrogen). Samples were labeled and hybridized to Illumina human 6 oligonucleotide arrays. Normalization and model-based expression measurements were performed using the Illumina analysis package (LUMI) available through open-source Bioconductor project (www.bioconductor.org) within the statistical programming language R (http://cran.r-project.org/). Pairwise comparisons were performed using the Linear Models for Microarray Data package (LIMMA) available through Bioconductor. Genes found to have an adjusted p-value ,0.05 were considered significant.
Statistical Analysis
Statistical analysis was performed using Prism for Mac version 5.0a. Unpaired, two-tailed T tests were performed comparing control cell lines versus ZFX Over clones.
BAC FISH
Metaphase harvest. Sub-confluent cultures were treated with 0.1 ug/ml Colcemid (Karyomax, Invitrogen) for 60-90 minutes before harvesting according to standard cytogenetics proce- dures. Briefly, cells were trypsinized to a single cell suspension, pelleted at 250 g for 5 minutes and resuspended in warm 0.075M KCl. After 8 minutes incubation at 37uC, the hypotonic was diluted with approximately 1/4 volume of 3:1 methanol/glacial acetic acid fixative, gently mixed, and the cells pelleted as before. The supernatant was removed and the cell pellet loosened by gently flicking the base of the tube. The cells were then fixed in 3 changes of fixative. Fixed cell suspensions were stored at 220uC. Fixed metaphase preparations were dropped onto dry slides and the quality of spreading assessed by phase microscopy. Slides were then air-dried and aged at 37uC overnight. Hybridization. DNA for human BAC clone RP11-1107D4 (BACPAC Resources, Children's Hospital and Research Center at Oakland), spanning the ZFX locus, was labeled by nick translation with Red dUTP (Enzo Life Sciences Inc., supplied by Abbott Molecular Inc.), and hybridized to metaphase slides. Briefly, approximately 100 ng of labeled probe and 1 ug human Cot-1 DNA (Invitrogen) was mixed with hybridization buffer (50% formamide, 26SSC,10% dextran sulfate, 0.1% SDS, 16Den-hardt's solution, 40 mM sodium phosphate buffer, pH7) and applied to each slide before sealing under a coverslip with rubber cement. The slides were then placed in a HYBrite TM (Abbott Molecular), denatured at 72uC for 3uminutes, and then hybridized at 37uC overnight. After coverslip removal in 26SCC, 0.1% Igepal CA 630 at room temperature, the slides were washed in 0.46SSC, 0.3% Igepal at 73uC for 2uminutes, then in 26SCC, 0.1% Igepal at RT, and rinsed briefly in 26SSC. The slides were then stained in 0.08 mg/ml DAPI in 26SSC for 3 minutes, rinsed, air-dried, then mounted in antifade solution (Vectashield, Vector Labs), and stored at 4uC. Slides were scanned using a Zeiss Axioplan 2i epifluorescence microscope equipped with a megapixel CCD camera (CV-M4 
Results
ZFX Knockdown in Human ESCs
Zfx is essential for the self-renewal of mouse ESCs and hematopoietic stem cells. To test whether ZFX is required in human ESCs, we used a lentiviral vector system to efficiently and stably knockdown (KD) ZFX in hESCs. To characterize the extent of ZFX knockdown, initial experiments were performed in leukemia cell lines where three of the five shRNAs tested caused a strong knockdown of ZFX expression levels and a concomitant growth impairment (data not shown). H9 hESCs cells were transduced with these 3 ZFX knockdown viruses before puromycin selection. All 3 of the vetted ZFX knockdowns caused a marked decrease in the number and size of colonies relative to the scrambled shRNA control ( Figure 1A and 1B) . We confirmed that ZFX RNA ( Figure 1C ) and protein ( Figure 1D ) levels were reduced. This data suggests that ZFX expression is required for the efficient self-renewal of hESCs similar to its role in mESCs. We next turned to ZFX overexpression since the ZFX knockdown cells could not be readily expanded, confounding analysis.
Production of ZFX Overexpressing Human ESCs
Similar to many transcription factors, the overexpression of ZFX cDNA from a heterologous promoter is toxic to cells (B.R., unpublished data). To overexpress murine Zfx under its native regulation, the entire genomic Zfx locus has been introduced into mESC as a bacterial artificial chromosome (BAC) transgene [13] . We have developed a method for stable BAC introduction into hESC to serve as reporter transgenes [17] . We adapted this approach to introduce additional copies of the human ZFX locus as BAC transgene in the H9 hESC. Several nucleofected H9 clones showed increased ZFX mRNA expression by quantitative RT-PCR (Figure 2A ). We chose two clones (ZFX Over1 and ZFX Over2 ) with the highest ZFX expression levels and compared them to the parental H9 line, a control clone (ZFX Normal ) with normal ZFX expression levels from the same experiment, as well as independent H9 GFP and YFP-expressing BAC transgenic reporter lines from our earlier studies (see Table 1 for a comprehensive description of controls used in this study) [17, 20] . We verified that the BAC reporter control clones expressed normal amounts of ZFX (data not shown).
As shown in Figure 2B , ZFX Over clones expressed more ZFX protein than the parental hESC line (H9) or ZFX Normal ( Figure 2B ). Fluorescent in situ hybridization (FISH) showed that the ZFX Over clones harbored multiple copies of the BAC integrated at a single site while ZFX Norma l lacked detectable ZFX BAC DNA despite being drug resistant ( Figure S2 ). Furthermore, ZFX Over2 , the control clone and the H9 parental line had normal karyotypes, whereas ZFX Over1 showed a mixture of normal cells and karyotypically abnormal cells (data not shown). Stem cell surface markers on each clone looked similar to H9: they were positive for hESC markers SSEA-4+ and Oct-4+ and variegated for Tra1-81 ( Figure 2C ; Figure S3 ) suggesting that all clonal lines are in a similar undifferentiated state.
ZFX-overexpressing hESC are More Clonogenic
Under standard growth conditions, all hESC clones had similar morphologies, growth and apoptosis rates as the parental H9 hESC line ( Figure S4 ). In addition to colony number, the size of the ZFX Over colonies derived from single cells was larger compared to controls (Figure 3 and Figure  S1 ). These data demonstrate that ZFX overexpression in hESCs results in cultures enriched in colony-forming cells, a sensitive assay of the undifferentiated state [22] .
Reduced Spontaneous Differentiation in ZFX Over cells
Next we tested the growth of ZFX Over clones under conditions suboptimal for hESC self-renewal. ZFX Over and control hESC lines were cultured in the absence of conditioned media or feeder cells to promote spontaneous differentiation, and the percentage of cells expressing SSEA-3 and SSEA-1 was measured to quantify the ratio of undifferentiated versus differentiated cells, respectively. In control experiments, there was no statistical difference in marker expression when conditioned media was used to expand cells without feeders (data not shown). However, in suboptimal conditions, H9 and the control clones showed strong signs of differentiation while the ZFX Over cells resisted spontaneous differentiation (Figure 4 ; Figure S5 ). The control cultures had low percentages of the undifferentiated hESC marker SSEA-3 (combined mean of 33.1262.62% SEM; n = 13) while ZFX (772.76211.2 AU SEM, n = 3; p = 0.0002). Taken together, these data show that ZFX overexpression promotes self-renewal of hESCs and inhibits differentiation in suboptimal culture conditions.
To test whether higher ZFX levels globally prohibit ESC differentiation, ZFX Over clones, two BAC transgenic control clones (ID1::YFPc2 and Dll1::GFPc277) and H9 were directed into endoderm or neural tissue and we examined lineage marker expression during differentiation using quantitative RT-PCR. We detected no significant difference in the loss of Nanog expression or gain in CXCR4 expression in ZFX Over clones during endodermal differentiation ( Figure 5 ). During neural differentiation, ZFX Over clones showed delayed Nanog downregulation and Pax6 induction on day 3 but no difference at later time points. These data show that ZFX overexpression reduces spontaneous differentiation yet permits directed differentiation, thus leaving hESC pluripotency intact.
Gene Expression Profile of ZFX Over cells
To gain insight into the genome-wide expression changes due to ZFX overexpression, we performed microarray analysis in ZFX Over hESCs. In order to avoid any systematic bias in the gene expression analysis due to varying levels of spontaneous differentiation in ZFX Over versus controls, we isolated the most undifferentiated 
Discussion
In the current study we demonstrate a role for the transcription factor ZFX in modulating the self-renewal of hESC using gainand loss-of-function approaches. ZFX reduction caused a loss of self-renewal while BAC-mediated ZFX overexpression increased the clonogenicity and decreased spontaneous differentiation of hESCs. Importantly, ZFX-overexpressing clones retained their ability to undergo differentiation in response to appropriate stimuli. The use of BAC transgenesis was critical to circumvent general toxic effects of ZFX overexpression observed using heterologous promoters. Gene expression driven by the endogenous gene locus in a BAC provides advantages over heterologous promoters, such as native gene regulation, reduced position effect [23] and copy number-dependent expression [24] . Until now, BACs were used to direct reporter gene expression [17] or as vehicles for homologous recombination in hESC [25] . We believe this study is the first to demonstrate their utility as vectors for functional gene expression in hESCs.
Because the extrinsic self-renewal signals, morphology and clonogenicity differ between human and mouse ESCs, it is critical to identify the self-renewal regulators that are conserved between the two species. Here we provide evidence for the functional conservation of ZFX, a critical member of the self-renewal transcriptional network. Our gain-of-function studies in hESCs are compatible with our previous work in mESCs demonstrating enhanced self-renewal and reduced spontaneous differentiation in both murine and human ESC. However, ZFX-overexpressing hESC underwent normal lineage-specific differentiation in vitro, while forced differentiation in Zfx-overexpressing murine ESC led to a severely impaired differentiation response [13] . While we currently do not know the reason for these differences between mouse and human ESCs, we cannot rule out that they simply reflect different levels of overexpression (,3-fold overexpression in hESC compared to .8-fold in the examined clones of murine ESC). Interestingly, the genes affected by Zfx overexpression in murine ESC (S.H., unpublished) and human ESC (this study) show little overlap. This may reflect the differences in the experimental approaches and microarray platforms used, and/or highlight the species-specific gene expression profiles of undifferentiated ESC. In any case, our data highlight the conserved cellintrinsic molecular control of ESC self-renewal by ZFX, despite the differences in extrinsic signals.
The enhanced self-renewal observed in ZFX-overexpressing clones could reflect a reduction in the baseline heterogeneity of cultured ESC. This hypothesis is supported by the increased plating efficiency of ZFX Over clones and by a small but reproducible increase in the percentage of cells expressing undifferentiated hESC markers (data not shown). It is possible that high ZFX levels stabilize a chromatin conformation that favors self-renewal over differentiation. This 'locked' state could also explain the kinetic delay in neural differentiation observed in ZFX-overexpressing hESC. Alternatively, ZFX overexpression may convert hESC from their primed state into a less differentiated, naïve state characteristic of murine ESC. Indeed, many of the genes downregulated in ZFX Over clones are expressed in mouse epiblast stem cells isolated from the postimplantation embryo [9, 10] . However, clonal replating experiments without the ROCK inhibitor Y-27632 showed poor clonal replating despite ZFX overexpression (data not shown), arguing against a truly naïve state. Nevertheless, it is possible that pluripotency is a continuum between the naïve and primed states, and that ZFX overexpression has moved the primed human ESCs toward a naïve state. If true, our data on ZFX overexpression may aid in defining a currently elusive, mouse ESC-like, pluripotent state in hESCs. The functional characterization of the potential ZFX target genes in hESCs reported here may contribute to the Figure S4 ZFX Over clones do not have differences in cell growth nor apoptosis during normal passage. A. hESC lines were passaged on day 0 using dispase and were counted the day after passage to assess seeding (day 1). Six days later, cells were counted to assess growth kinetics (day 7). On day 7, cells were passaged again using dispase and counted the day after (day 8). The same process was repeated on days 14 and 15. B. hESC lines were grown in feeder free conditions and the number of cells with AnnexinV staining were quantitated. No differences were observed after dispase passage. Three independent experiments were performed both for A and B and the data were not significantly different in either case. (TIF) Figure S5 All data from the spontaneous differentiation experiment shown in Figure 4 . Three independent experiments showing the level of SSEA-1 and SSEA-3 after 7 days of suboptimal culture. The mean fluorescent intensity is diagrammed on the right side of the figure: controls are grouped on the left side, ZFX Over1 in the middle and ZFX Over2 on the right. (TIF)
